Our Technology
EyeSol
®
Novel Drug Product Creation
Chemistry Manufacturing Control (CMC)
Disease Areas & Pipeline
Pipeline
Dry Eye Disease
Glaucoma
Dermatology
Products
CyclASol
®
NOV03 (perfluorohexyloctane)
BTQ 1901 / BTQ 1902
Novatears
®
(perfluorohexyloctane)
Novatears
®
+Omega-3
News & Media
Company Presentation
Press Releases
Publications
About us
Management
Supervisory Board
Our Partners
Contact
Novaliq in USA
Careers
Investor Relation
Our Technology
EyeSol
®
Novel Drug Product Creation
Chemistry Manufacturing Control (CMC)
Disease Areas & Pipeline
Pipeline
Dry Eye Disease
Glaucoma
Dermatology
Products
CyclASol
®
NOV03 (perfluorohexyloctane)
BTQ 1901 / BTQ 1902
Novatears
®
(perfluorohexyloctane)
Novatears
®
+Omega-3
News & Media
Company Presentation
Press Releases
Publications
About us
Management
Supervisory Board
Our Partners
Contact
Novaliq in USA
Careers
Investor Relation
Publications
Explore a selection of scientific articles
Publications
Peer Reviewed Publications of Novaliq
Poster
Peer Reviewed Publications about Ophthalmology and technology
General Publications
